Welcome to SAfAIDS
SAfAIDS Statement on the Day of the African Child – Ending Child Marriage is a Priority
BOSTON, 01 March 2016 (Aidsmap)- Entry into HIV care can be increased by around 40% if people receive a point-of-care CD4 test and counselling sessions to overcome personal barriers to seeking HIV care, a large randomised study in South Africa has shown. However, the study also found that only half of the people who received the most effective linkage intervention and who were in need of immediate treatment made it onto treatment within six months of their HIV diagnosis, highlighting the need for further improvements in linkage to HIV care.
BOSTON, 01 March 2016 (Aidsmap)- Engaging lay counsellors to provide a combination package of evidence-based interventions in Nyanza, Kenya and addressing partner disclosure, as well as pre-treatment education about the benefits of antiretroviral therapy (ART) for maternal and child health in Malawi’s Option B+ programme, improved retention in care and reduced loss to follow-up of mothers with HIV and their infants, studies presented last week at the Conference on Retroviruses and Opportunistic Infections (CROI 2016) in Boston show.
BOSTON, 27 February 2016 (Aidsmap)- In four years, Malawi’s treatment cascade for pregnant women has been transformed so that the proportion of women with HIV who are diagnosed has gone from 49 to 80%, and the proportion who are virally suppressed has jumped from 2 to 48%, the Conference on Retroviruses and Opportunistic Infections (CROI 2016) in Boston heard this week.
BOSTON, 22 February 2016 (sciencedaily) - A vaginal ring containing an antiretroviral (ARV) drug called dapivirine that women use for a month at a time was safe and helped protect against HIV in a large-scale clinical trial involving more than 2,600 women in Africa, researchers who conducted the trial, known as ASPIRE, reported.
NAIROBI, 23 February 2016 (allAfrica) - A transition preparedness assessment framework has been developed for the Global Fund by Curatio International Foundation (CIF), a Georgian NGO. The framework is designed to allow countries to assess their readiness to fully fund and implement their TB and HIV programs once they no longer receive financial support from The Global Fund and other donors.
Africa: Johnson & Johnson Issues Call for Innovative Ideas to Reduce HIV Infections in Sub-Saharan Africa
NEW JERSEY, 17 February 2016 - Johnson & Johnson (NYSE: JNJ) today issued a call for innovative ideas as part of the DREAMS Innovation Challenge, which is supported by the U.S. President's Emergency Plan for AIDS Relief (PEPFAR), Janssen Pharmaceutica, NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, and ViiV Healthcare. Proposals are currently being accepted for breakthrough innovations to reduce HIV infections in adolescent girls and young women in 10 sub-Saharan African countries.